Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This trial is globally conducted. The aim of this trial is to investigate Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation versus Sitagliptin in Subjects with Type 2 Diabetes Mellitus.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Main phase (the inclusion criteria for the main phase are not reassessed for the extension phase):
Extension phase:
Exclusion criteria
Main phase (the exclusion criteria for the main phase are not reassessed for the extension phase):
Extension phase: There are no new exclusion criteria for the extension phase
Primary purpose
Allocation
Interventional model
Masking
504 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal